Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ConforMIS Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
CFMS
Nasdaq
3841
http://www.conformis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ConforMIS Inc
Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022
- Jan 23rd, 2023 9:30 pm
Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule
- Nov 30th, 2022 9:30 pm
Conformis Announces First Procedure Performed Using New Actera™ Hip System
- Nov 29th, 2022 12:30 pm
Conformis Announces Full Commercial Launch of Imprint™
- Nov 17th, 2022 12:00 pm
Conformis, Inc. Announces Settlement of Medacta Patent Litigation
- Nov 14th, 2022 9:15 pm
Conformis, Inc.'s (NASDAQ:CFMS) 48% loss last week hit both individual investors who own 52% as well as institutions
- Nov 11th, 2022 1:41 pm
Conformis, Inc. Effects 1-for-25 Reverse Stock Split
- Nov 9th, 2022 12:00 pm
ConforMIS (CFMS) Reports Q3 Loss, Misses Revenue Estimates
- Nov 2nd, 2022 11:25 pm
Conformis Reports Third Quarter 2022 Financial Results
- Nov 2nd, 2022 8:10 pm
Conformis, Inc. to Announce Financial Results for Its Third Quarter 2022
- Oct 5th, 2022 8:30 pm
Conformis Actera™ Hip System Receives 510(k) Clearance from the U.S. Food and Drug Administration
- Sep 13th, 2022 8:30 pm
Conformis, Inc. to Participate in the H.C. Wainwright & Co. 24th Annual Global Investment Conference
- Aug 29th, 2022 8:30 pm
Investors in Conformis (NASDAQ:CFMS) from five years ago are still down 89%, even after 32% gain this past week
- Aug 13th, 2022 12:40 pm
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates
- Aug 8th, 2022 10:05 pm
Conformis Reports Second Quarter 2022 Financial Results
- Aug 8th, 2022 8:45 pm
Conformis Shares Jump On Personalized Orthopedic Implants Contract
- Aug 2nd, 2022 1:37 pm
Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants
- Aug 1st, 2022 8:30 pm
Conformis, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
- Jul 28th, 2022 8:30 pm
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
- Jul 5th, 2022 8:30 pm
Rock star Growth Puts Conformis (NASDAQ:CFMS) In A Position To Use Debt
- Jun 3rd, 2022 1:01 pm
Scroll